PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 31652143-1 2020 PURPOSE OF REVIEW: Because arginine is the substrate for nitric oxide synthesis, which is pivotal to vascular homeostasis and linked to the insulin response, it has long been posited that supplemental arginine could benefit cardiometabolic health. Arginine Vasopressin 27-35 insulin Homo sapiens 140-147 31802616-5 2020 The primary outcome of the study was the mean change in arginine-stimulated insulin secretion rate during the hyperglycemic clamp test from baseline to 16-week therapy RESULTS: At week 16, BMI declined in all groups (-1.2+-0.2 Kg/m2 ; p<0.05). Arginine Vasopressin 56-64 insulin Homo sapiens 76-83 32077280-5 2020 In vivo, GNF2133 demonstrated significant dose-dependent glucose disposal capacity and insulin secretion in response to glucose-potentiated arginine-induced insulin secretion (GPAIS) challenge in rat insulin promoter and diphtheria toxin A (RIP-DTA) mice. Arginine Vasopressin 140-148 insulin Homo sapiens 87-94 31730979-7 2020 Docking experiment and subsequent molecular dynamics simulation indicated possible sites of interaction for arginine with the B-chain of insulin. Arginine Vasopressin 108-116 insulin Homo sapiens 137-144 31983031-4 2020 RESULTS: At both 4 and 24 weeks post-RYGB the following effects were found: arginine-stimulated insulin secretion was reduced. Arginine Vasopressin 76-84 insulin Homo sapiens 96-103 31652143-1 2020 PURPOSE OF REVIEW: Because arginine is the substrate for nitric oxide synthesis, which is pivotal to vascular homeostasis and linked to the insulin response, it has long been posited that supplemental arginine could benefit cardiometabolic health. Arginine Vasopressin 201-209 insulin Homo sapiens 140-147